Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1993 1
1996 1
1997 1
1999 2
2002 1
2004 1
2008 1
2019 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
COMT inhibitors in Parkinson's disease.
Rivest J, Barclay CL, Suchowersky O. Rivest J, et al. Among authors: barclay cl. Can J Neurol Sci. 1999 Aug;26 Suppl 2:S34-8. doi: 10.1017/s031716710000007x. Can J Neurol Sci. 1999. PMID: 10451758 Review.
Dystonia in progressive supranuclear palsy.
Barclay CL, Lang AE. Barclay CL, et al. J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):352-6. doi: 10.1136/jnnp.62.4.352. J Neurol Neurosurg Psychiatry. 1997. PMID: 9120447 Free PMC article.
Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease.
Whone AL, Boca M, Luz M, Woolley M, Mooney L, Dharia S, Broadfoot J, Cronin D, Schroers C, Barua NU, Longpre L, Barclay CL, Boiko C, Johnson GA, Fibiger HC, Harrison R, Lewis O, Pritchard G, Howell M, Irving C, Johnson D, Kinch S, Marshall C, Lawrence AD, Blinder S, Sossi V, Stoessl AJ, Skinner P, Mohr E, Gill SS. Whone AL, et al. Among authors: barclay cl. J Parkinsons Dis. 2019;9(2):301-313. doi: 10.3233/JPD-191576. J Parkinsons Dis. 2019. PMID: 30829619 Free PMC article.
Dementia with lewy bodies: implications for clinical trials.
Collins B, Constant J, Kaba S, Barclay CL, Mohr E. Collins B, et al. Among authors: barclay cl. Clin Neuropharmacol. 2004 Nov-Dec;27(6):281-92. doi: 10.1097/01.wnf.0000148388.56605.d9. Clin Neuropharmacol. 2004. PMID: 15613933 Review.
Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease.
Whone A, Luz M, Boca M, Woolley M, Mooney L, Dharia S, Broadfoot J, Cronin D, Schroers C, Barua NU, Longpre L, Barclay CL, Boiko C, Johnson GA, Fibiger HC, Harrison R, Lewis O, Pritchard G, Howell M, Irving C, Johnson D, Kinch S, Marshall C, Lawrence AD, Blinder S, Sossi V, Stoessl AJ, Skinner P, Mohr E, Gill SS. Whone A, et al. Among authors: barclay cl. Brain. 2019 Mar 1;142(3):512-525. doi: 10.1093/brain/awz023. Brain. 2019. PMID: 30808022 Free PMC article. Clinical Trial.
12 results